Clinical Nuclear Medicine

Skip Navigation LinksHome > May 2014 - Volume 39 - Issue 5 > Peptide Receptor Radionuclide Therapy With 177Lu DOTATATE in...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0000000000000273
Interesting Images

Peptide Receptor Radionuclide Therapy With 177Lu DOTATATE in a Case of Recurrent Carotid Body Paraganglioma With Spinal Metastases

Gupta, Santosh Kumar MSc; Singla, Suhas MD; Karunanithi, Sellam MD; Damle, Nishikant MD; Bal, Chandrasekhar MD, DSc (HC)

Collapse Box


Abstract: Paragangliomas are rare benign neuroendocrine tumors, and 80% of all paragangliomas are either carotid body tumors or glomus jugulare tumors. We present a case of recurrent unresectable carotid body paraganglioma with nodal and T7 vertebral metastases in a 30-year-old man 6 years postsurgery detected with 68Ga DOTANOC PET/CT and was administered with peptide receptor radionuclide therapy using 177Lu DOTATATE. After 5 cycles of 177Lu DOTATATE (total cumulative activity of 750 mCi [27 GBq]), significant response at the primary site on 68Ga DOTANOC PET/CT and complete disappearance of nodal and T7 vertebral metastases were noted.

© 2014 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.